Inombolo yeRifampicin Cas: 13292-46-1 Ifomula yeMolekyuli: C43H58N4O12
Indawo yokunyibilika | 183 ° |
Ukuxinana | 1.1782(uqikelelo olurhabaxa) |
ixesha lokugcina | 2-8°C |
ukunyibilika | i-chloroform: i-soluble50mg/mL, icacile |
umsebenzi wamehlo | N / A |
Imbonakalo | ibomvu ebomvu ukuya kubomvu obumnyama kakhulu |
Ubunyulu | ≥99% |
I-Rifampicin yi-semisynthetic derivative ye-rifamicin B, i-macrolactam antibiotic kunye nenye yamayeza okubulala iintsholongwane angaphezu kwesihlanu kumxube we-rifamicins A, B, C, D, no-E, obizwa ngokuba yi-rifamicin complex, eveliswa yi-actinomycetes Streptomyces mediteranei ( Nocardia mediteranei).Yaziswa kunyango ngo-1968. I-Synthesis ye-rifampicin iqala ngesisombululo esimanzi se-rifamicin, phantsi kweemeko zokusabela i-oxidized kwi-derivative entsha ye-rifamicin S (32.7.4), kunye nokusekwa okuphakathi kwe-rifamicin O (32.7. 3).Ukunciphisa i-quinone yale mveliso nge-hydrogen usebenzisa i-palladium kwi-carbon catalyst inika i-rifamicin SV (32.7.5).Imveliso ephumelayo ifumana i-aminomethylation ngomxube we-formaldehyde kunye ne-pyrrolidine, ukunika i-3-pyrrolidinomethylrifamicin SV (32.7.6).I-Oxidizing imveliso ephumayo kunye ne-lead tetracetate kwi-enamine kunye ne-hydrolysis elandelayo kunye nesisombululo esimanzi se-ascorbic acid inika i-3-formylrifamicin SV (32.7.7).Ukuphendula oku nge-1-amino-4-methylpiperazine kunika i-rifampicin efunekayo (32.7.8).
I-Rifampin isetyenziswa njengeyeza lokubulala iintsholongwane.Yinto ephuma kwi-semisynthetic ye-rifamycin B, isithinteli-ntsholongwane se-macrocyclic esiveliswe ngumbumba iStreptomyces mediterranei.I-Rifampin isetyenziselwa unyango lwesifo sephepha, i-brucellosis, i-Staphlococcus aureus, kunye nezinye izifo ezithathelwanayo.